┃ 包装、出口、个护上游原材料涉及石化衍生品 | 板块 | 公司 | 主营产品 | 石化类原材料 | 石化类原材料/营业成本 | | --- | --- | --- | --- | --- | | 包装 | 新巨手 | 无菌包装 | 聚乙烯 | 24% | | | 永新股份 家联科技 | 塑料薄膜 塑料日用品 | PE薄膜/BOPP PP/PS | 64% 53% | | | 共创草坪 | 人造草坪 | PE/PP | 34% | | | 天振股份 | PVC地板 | PVC树脂粉 | 20% | | 轻工出口 | 海象新材 | PVC地板 | PVC树脂粉 | 22% | | | 爱丽家居 | PVC地板 | PVC树脂粉 | 22% | | | 梦百合 | 乳胶床垫 | 娶醚/TDI/MDI | 32% | | | 玉马遮阳 | 遮阳面料 | 娶酯纤维/PVC | 36% | | | 浙江自然 | 户外帐篷/充气床垫 | TPU /TDI/聚醚多元醇 | 25% | | 个护 | 自亚股份 | ア生巾 | 无纺布/PE膜/SAP | 39% | | | 依依股份 | 宠物护垫/无纺布 | 无纺布/聚丙烯/ ...

Group 1 - The core viewpoint indicates that Haoyue Care (605009) has shown revenue growth but profit pressure, with 2025 revenue at 2.718 billion yuan, up 33.18%, while net profit decreased by 30.94% to 203 million yuan [1] - The gross margin improved by 11.97 percentage points to 31.7%, but operating cash flow per share dropped significantly by 81.06% to 0.31 yuan, highlighting challenges in operational efficiency [1] - Institutions predict a 7.87% decline in net profit for 2025, but a potential recovery of 15.94% growth in 2026, emphasizing the need to monitor cash flow improvements for long-term fundamentals [1] Group 2 - Institutional ratings for Haoyue Care are generally neutral, with a target price of 49.00 yuan, indicating a potential upside of 58.78% from the current stock price [2] - Revenue is expected to reach 3.872 billion yuan in 2025, a year-on-year increase of 32.18%, although net profit growth remains under pressure; a rebound in net profit growth to 15.94% is anticipated for 2026 [2] - Current institutional research frequency is low, with fund ownership at only 0.05%, suggesting average market attention and the need to monitor future performance [2] Group 3 - Over the past 7 trading days (February 6 to 12, 2026), Haoyue Care's stock price has fluctuated downwards, with a total decline of 3.18%, including a single-day drop of 2.29% to 30.71 yuan on February 12 [3] - On that day, there was a net outflow of 6.0281 million yuan from major funds, while retail investors dominated the inflow [3] - Technical indicators show the stock price nearing the lower Bollinger Band support level of 30.36 yuan, with a weak MACD indicator, necessitating attention to support around 30.46 yuan in the short term [3]

Core Insights - The report maintains a positive investment rating for the light industry sector, indicating a favorable outlook for potential investments [2][5] - The electronic cigarette industry in China is experiencing significant growth, with the leading brand, RELX, showing a revenue increase of 45.60% year-on-year for the first three quarters of 2025, alongside improvements in gross margin to 29.30% and net margin to 23.00% [5][27] - The industry is undergoing a transformation due to stringent regulations, leading to increased market concentration and providing opportunities for compliant and technologically advanced companies [5][27] Company Overview - The company, RELX Technology, focuses on the research, design, and sales of consumer-grade electronic vapor products, primarily through a comprehensive offline distribution and "brand store+" retail model [8][12] - The management team consists of experienced professionals with backgrounds in fast-moving consumer goods and technology, enhancing the company's strategic direction and operational management [11] Financial Performance - The company's financial data indicates a robust recovery, with a significant increase in net profit for the first three quarters of 2025, reflecting a strong operational performance [16][18] - The sales expense ratio has decreased significantly, contributing to improved profitability metrics [21] Industry Situation - The domestic electronic cigarette market is undergoing consolidation due to strong regulatory measures, with a comprehensive control system established for production, sales, and taxation [27] - Internationally, the market shows regional differentiation, with emerging markets becoming key growth areas while facing high entry barriers in developed regions [28] Competitive Advantages - The company has established a competitive edge through early compliance with regulations, a strong R&D framework supported by multiple laboratories and patents, and a robust supply chain management strategy [29][30] - The dual strategy of deepening domestic compliance while expanding into international markets positions the company favorably against competitors [29]

Investment Rating - The report assigns a "Buy" rating to the company with a target price of 38 HKD [3][6]. Core Insights - The company, Leshu Shi (2698.HK), is a leading multinational hygiene products company focused on emerging markets such as Africa, Latin America, and Central Asia, specializing in baby diapers, pull-ups, sanitary napkins, and wet wipes [1][2]. - Revenue for the first four months of 2024 and 2025 was 320 million and 160 million USD, respectively, showing year-on-year growth of 10.5% and 15.5%, while net profit was 95 million and 31 million USD, reflecting growth of 47.0% and 8.4% [1]. - The company is expected to see net profits of 106 million, 129 million, and 147 million USD for 2025, 2026, and 2027, respectively, with corresponding EPS of 0.18, 0.21, and 0.24 USD [1][3]. Company Overview - Leshu Shi has established a broad sales network across over 30 countries in Africa, Latin America, and Central Asia, with 18 sales branches and over 2,800 wholesalers, distributors, supermarkets, and other retailers [2][17]. - The company has a strong local production presence in Africa with 8 factories, making it the largest manufacturer of hygiene products in the region [2][20]. Business Growth Factors - Future growth is anticipated from external factors such as demographic growth in emerging markets, ongoing consumption upgrades, and increased penetration of hygiene products [3][12]. - Internal growth factors include localized production creating a competitive moat, extensive sales channel coverage, continuous product category expansion, and replicating successful market experiences in other emerging markets [3][12]. Financial and Valuation Summary - The company’s projected revenues for 2025, 2026, and 2027 are 541 million, 627 million, and 711 million USD, with growth rates of 19.1%, 15.9%, and 13.4% respectively [4]. - The net profit margins are expected to remain stable, with net profit margins of 19.6%, 20.5%, and 20.7% for the years 2025, 2026, and 2027 [4]. - The company is valued at a 23x PE ratio for 2026, corresponding to a stock price of 38 HKD [3][4]. Market Characteristics - Emerging markets, particularly Africa, are characterized by strong economic growth, a young population driving consumption upgrades, and high import demand due to lower local industrialization [46][47]. - The African market is expected to see significant growth in the hygiene products sector, with the baby diaper market projected to grow from 2.037 billion USD in 2020 to 2.590 billion USD by 2024, reflecting a CAGR of approximately 6.2% [49][53].

Market Overview - The personal care products sector increased by 0.24% compared to the previous trading day, with Liangmianzhen leading the gains [1] - The Shanghai Composite Index closed at 4102.2, up by 0.85%, while the Shenzhen Component Index closed at 14156.27, up by 0.21% [1] Stock Performance - Liangmianzhen (600249) closed at 5.99, with a rise of 1.35% and a trading volume of 100,500 shares, amounting to a transaction value of 60.56 million yuan [1] - Reliable Co. (600100E) closed at 13.35, up by 1.14%, with a trading volume of 23,200 shares and a transaction value of 30.87 million yuan [1] - Zhongshun Jierou (002511) closed at 8.02, up by 1.13%, with a trading volume of 218,400 shares, totaling 174 million yuan [1] - Runben Co. (603193) closed at 23.80, up by 0.89%, with a trading volume of 19,800 shares and a transaction value of 46.86 million yuan [1] - Stable Medical (300888) closed at 35.58, up by 0.88%, with a trading volume of 32,300 shares, amounting to 114 million yuan [1] Fund Flow Analysis - The personal care products sector experienced a net outflow of 59.46 million yuan from institutional investors, while retail investors saw a net inflow of 53.83 million yuan [2] - The main stocks with significant fund flow include Zhongshun Jierou, which had a net inflow of 12.05 million yuan from institutional investors [3] - Reliable Co. had a net inflow of 1.09 million yuan from retail investors, despite a net outflow of 1.75 million yuan from institutional investors [3]

Core Viewpoint - The personal care products sector experienced a rise of 1.23% on February 3, with Beijia leading the gains, while the overall market indices also showed positive performance [1] Group 1: Market Performance - The Shanghai Composite Index closed at 4067.74, up by 1.29% [1] - The Shenzhen Component Index closed at 14127.1, up by 2.19% [1] - The personal care products sector stocks showed varied performance, with Beijia's stock price increasing by 4.91% to 40.60 [1] Group 2: Stock Performance Details - Beijia (603059) led the sector with a closing price of 40.60 and a trading volume of 55,200 shares, amounting to a transaction value of 223 million [1] - Yanjing Co. (300658) followed with a closing price of 16.45, up by 4.05%, and a transaction value of 571 million [1] - Other notable stocks included Yiyi Co. (001206) at 25.25 (+2.64%), Ziya Co. (003006) at 21.66 (+1.50%), and Wanjian Medical (300888) at 35.27 (+0.94%) [1] Group 3: Fund Flow Analysis - The personal care products sector saw a net outflow of 66.63 million from institutional investors, while retail investors contributed a net inflow of 67.69 million [1] - Detailed fund flow for individual stocks showed that Yiyi Co. had a net inflow of 9.28 million from institutional investors, while Beijia experienced a net outflow of 8.49 million from retail investors [2] - The overall trend indicated that while institutional investors withdrew funds, retail investors were actively buying into the sector [1][2]

Market Overview - The personal care products sector experienced a decline of 1.23% on February 2, with Yanjiang Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 4015.75, down 2.48%, while the Shenzhen Component Index closed at 13824.35, down 2.69% [1] Stock Performance - Notable gainers in the personal care sector included: - Beijiajie (603059) with a closing price of 38.70, up 3.78% on a trading volume of 80,800 shares and a transaction value of 308 million yuan [1] - Zhiya Co., Ltd. (003006) closed at 21.34, up 2.99% with a trading volume of 86,300 shares and a transaction value of 184 million yuan [1] - Dengkang Oral (001328) closed at 40.88, up 2.58% with a trading volume of 31,500 shares and a transaction value of 129 million yuan [1] - Major decliners included: - Yanjiang Co., Ltd. (300658) closed at 15.81, down 12.17% with a trading volume of 418,300 shares and a transaction value of 686 million yuan [2] - Zhongshun Jiesang (002511) closed at 7.92, down 2.82% with a trading volume of 277,300 shares and a transaction value of 223 million yuan [2] Capital Flow - The personal care products sector saw a net outflow of 114 million yuan from institutional investors, while retail investors experienced a net inflow of 28.68 million yuan [2] - The capital flow for key stocks in the sector included: - Haoyue Nursing (605009) had a net inflow of 2.75 million yuan from institutional investors, but a net outflow of 2.32 million yuan from retail investors [3] - Beijiajie (603059) saw a net inflow of 2.44 million yuan from institutional investors and a net outflow of 17.41 million yuan from retail investors [3] - Yanjiang Co., Ltd. (300658) experienced a significant net outflow of 13.22 million yuan from institutional investors [3]

证券代码：605009 证券简称：豪悦护理 公告编号：2026-008 天健作为公司2025年度财务报表及2025年末财务报告内部控制审计机构，原委派李新葵作为公司2025年 度财务报表审计报告和2025年末财务报告内部控制审计报告的项目质量复核人。由于内部工作安排变 动，现委派张扬接替李新葵作为项目质量复核人。变更后的项目质量复核人为张扬。 二、本次变更项目质量复核人的基本情况 1、基本信息 张扬，2009年4月成为中国注册会计师，自2013年11月开始在天健执业。 杭州豪悦护理用品股份有限公司关于变更项目质量复核人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 杭州豪悦护理用品股份有限公司（以下简称"公司 "或"豪悦护理"）分别于2025年4月14日、2025年5月 12日召开了第三届董事会第十四次会议、2024年年度股东大会，审议通过了《关于续聘2025年度会计师 事务所的议案》，同意聘请天健会计师事务所（特殊普通合伙）（以下简称" 天健 "）为公司2025年度 财务审计机构和内部控制审计机构。具体详见公司于20 ...

Market Overview - The personal care products sector experienced a decline of 1.66% on January 30, with Zhongshun Jierou leading the drop [1] - The Shanghai Composite Index closed at 4117.95, down 0.96%, while the Shenzhen Component Index closed at 14205.89, down 0.66% [1] Stock Performance - The following stocks in the personal care sector showed notable performance: - Beijiajie (603059) increased by 10.00% to a closing price of 37.29, with a trading volume of 32,300 hands and a turnover of 118 million [1] - Reliable Co. (301009) rose by 1.21% to 13.38, with a trading volume of 32,700 hands and a turnover of 43.52 million [1] - Liangmian Needle (600249) saw a slight increase of 0.51% to 5.92, with a trading volume of 112,700 hands and a turnover of 66.34 million [1] - Zhongshun Jierou (002511) fell by 5.45% to 8.15, with a trading volume of 482,800 hands and a turnover of 400 million [2] Capital Flow - The personal care products sector experienced a net outflow of 105 million from institutional investors, while retail investors saw a net inflow of 42.76 million [2] - The following stocks had significant capital flow: - Beijiajie (603059) had a net inflow of 20.94 million from institutional investors, but a net outflow of 15.94 million from retail investors [3] - Zhongshun Jierou (002511) faced a net outflow of 21.64 million from institutional investors [3] - Reliable Co. (301009) had a minor net inflow of 0.57 million from institutional investors [3]

证券代码：605009 证券简称：豪悦护理 公告编号：2026-008 杭州豪悦护理用品股份有限公司 一、本次变更的基本情况 天健作为公司2025年度财务报表及2025年末财务报告内部控制审计机构，原 委派李新葵作为公司2025年度财务报表审计报告和2025年末财务报告内部控制审 计报告的项目质量复核人。由于内部工作安排变动，现委派张扬接替李新葵作为 项目质量复核人。变更后的项目质量复核人为张扬。 二、本次变更项目质量复核人的基本情况 1、基本信息 张扬，2009年4月成为中国注册会计师，自2013年11月开始在天健执业。 关于变更项目质量复核人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 杭州豪悦护理用品股份有限公司（以下简称"公司"或"豪悦护理"）分别于 2025年4月14日、2025年5月12日召开了第三届董事会第十四次会议、2024年年度 股东大会，审议通过了《关于续聘2025年度会计师事务所的议案》，同意聘请天 健会计师事务所（特殊普通合伙）（以下简称"天健"）为公司2025年度财务审 计机构和内部控制审计 ...